by the protozoan Trypanosoma cruzi. It was first described protein nitration rather than focal immune cell lesions. in 1909 by the Brazilian physician Carlos Chagas who also Zidovudine (originally called AZT), developed in 1987 in reported the cycle of infection and the pathologic findings North Carolina for the treatment of AIDS, is an antiviral in each phase of the disease. The disease is endemic in drug used to reduce the severity of AIDS-related conLatin America with 16 to 18 million infected individuals ditions. However, one of the most important adverse and 100 million at risk for infection; as a result of modern effects of the drug is on the cardiovascular system. transportation and immigration, Chagas' heart disease is Hypertrophy of the interventricular septum, modified vasnow a worldwide problem, especially in the United States, cular smooth muscle responsiveness, and a modest inwhere also 500 000 persons are estimated to be infected. crease in systolic blood pressure have been shown by Ruga et al. [9] in rats treated with AZT for 240 days. Among 2 .1. In this spotlight issue non-viral infections, the present issue also focuses on Chagas' disease. De Lourdes Higuchi et al. [10] provide an Major factors that contribute to infectious myocarditis in-depth overview of the pathology of the heart in Chagas' and the various diagnostic modalities with particular disease. The authors emphasize that an inflammatory emphasis to molecular techniques like PCR and gene response with often accentuated exacerbation is most likely sequencing are extensively discussed by Calabrese et al.
responsible for progressive neuronal damage, microcir- [2] . Mason provides an overview of multiple pathogenetic culatory alterations and changes in extracellular matrix of mechanisms that play a crucial role in the development and the heart, ultimately leading to organ failure. progression of the disease [3] . As underlined by the author, many of these mechanisms that act in a chronological cascade can overlap in some cases, rendering the diagnosis and treatment difficult. progression from a stable vascular lesion to an unstable chronic heart failure. They conclude that the inflammatory (ruptured) plaque and ensuing acute vascular event has response of T-lymphocytes appears independent of the sparked the interest in the interaction between inflammaetiology of the disorder. Different proinflammatory cytotion and vascular disease. In fact, even low grade inflamkines have a critical role in the development and promation (for example as reflected by slightly elevated levels gression of myocarditis and many of the detrimental of C-reactive protein) seems to predict the clinical outcome effects on myocardium seem to be strictly related to of patients with atherosclerosis, in terms of developing overproduction of nitric oxide (NO). However, in the acute thrombotic events as a result of atherosclerotic experimental model of intrauterine infection Rounioja et plaque rupture. There are many areas of interest where al. [5] have demonstrated that severe foetal cardiac inflammation meets vascular biology, from vascular redysfunction is linked to overproduction of cytokines modelling as a response to inflammatory processes, inflamthrough mechanisms independent of NO. With the use of mation as part of ischemia-reperfusion syndromes, extenan animal model, Tessier et al.
[6] demonstrated the sive cross-talk between inflammation and coagulation, and occurrence of severe impairment of cardiac glucose metabmodulation of vascular cell and lipoprotein metabolism by olism in endotoxin-induced inflammation, thus providing inflammatory mediators. Conversely, pharmacological more insight into cardiac function during sepsis or critical agents known to interfere in vascular disease often display illness. Cardiac abnormalities are an important complicaadditional effects that interfere with inflammatory mechation of AIDS. Different etiological factors such as primary nisms. HIV infection of the myocardium, superinfections, subIt is a matter of debate whether the inflammatory stance abuse, HIV-related neoplasms or the sequelae of response is merely a matter of host-response upon developdrug therapy (highly active antiretroviral therapying vascular abnormalities and toxic agents or should be HAART) are reviewed by Barbaro [7] . Due to the adverse viewed as an underlying independent process in the effects of HAART, the author emphasizes the importance pathogenesis of vascular disease. In that respect the of careful assessing of HIV infected patients and patients hypotheses that infectious agents, eliciting inflammatory already under antiretroviral treatment. When HIV infection responses, may initiate or amplify atherosclerotic changes is the only principal etiological factor, the pathogenesis is is of interest. Although there are many infectious agents, yet not clear: direct retroviral action and / or focal infiltrasuch as Mycoplasma, Chlamydia species or Cytotion of activated immune cells have been mainly postmegalovirus, that have been implicated in the pathogenesis ulated. In mice with AIDS-related-cardiomyopathy Chaves of vascular disease and (remnants of) these agents someet al. [8] demonstrated an increase of cardiac myocyte times are identified in atherosclerotic lesions, it is still unclear whether these microorganisms are truly etiologic made in the field of cardiovascular infection and inflammation. The application of molecular techniques on myocarfactors rather than innocent bystanders. dial tissue has improved the sensitivity to detect viral inflammatory cardiomyopathy. Numerous studies of pa-3 .1. In this spotlight issue tients with myocarditis have demonstrated the usefulness of PCR analysis for etiologic diagnosis. These new diagKeller et al. [11] present a review on the effect of nostic tools in the future will enable a tailored therapy. The various infections on endothelial cells, describing a nummolecular determinants of cardiac viral infections are now ber of effects various pathogens may have on endothelial under intense investigation because an understanding of functions. Infections with Chlamydia pneumoniae and these determinants may lead to an explanation for the vascular disease are further highlighted in two original highly variable clinical course. In the modern molecular contributions. One of these manuscripts focuses on placenera the complex infective agents-host interaction will be tal infection with Chlamydia pneumoniae and intrauterine clarified which will lead to a better knowledge of ingrowth restriction [12] and the other deals with flammatory cardiomyopathy and will significantly change Chlamydia-induced atherosclerosis by modulation of inour management of this disease in the near future. ducible nitric oxide synthase [13] . The link between Similarly, in vascular disease, more knowledge on the infectious agents and cardiovascular disease is further various mechanisms that play a role in atherogenesis and outlined in the overview by de Kleijn et al. [14] focused on other types of vascular disorders will likely provide new the participation of the recently characterized family of therapeutic targets for prevention and treatment of disease. Toll-like receptors in the process of neointima formation Since infection and inflammation are intricately involved and atherosclerotic plaque formation. Another immunoin the pathogenesis of vascular disorders, it is likely that logical pathway involved in atherosclerosis is antigennew therapeutic strategies, aimed at components or pathspecific T-cell activation, in which a myriad of antigens ways of inflammatory responses will find a place in the appears to play a role, as explained in the review by de therapeutic armoury to prevent or treat vascular disease. Boer et al. [15] . Besides the important role of inflammatory cytokines as mediators of these inflammatory processes, other regulators of the immune response have R eferences recently been identified. Phospholipase A2 represent one of these mediatory pathways, as evidenced in the contribu-
